Cellectis
  • About
    Our mission
    Governance
    Partners
  • Science
    Our Genome Engineering Platform
    TALEN® Technology
    In-House Manufacturing
  • Pipeline
    Product Candidates
  • Investors
    IR Overview
    News
    • Press releases
    • Events and Webcasts
    Presentations
    • Corporate presentations
    • Scientific presentations
    • Scientific publications
    Corporate Governance
    • Board of Directors
    • Executive Committee
    • External Auditors
    • Governance Documents
    • General meetings
    Financial Information
    • SEC filings
    • Financial statements
    • Voting Rights & Share Capital
    • Stock information
    Shareholders Services
    • IR Inquiries
    • IR FAQ
  • Careers
    Our culture
    Job opportunities
  • Contact us
LinkedinX FR
› Events
  • About
    • Our mission
    • Governance
    • Partners
  • Science
    • Our Genome Engineering Platform
    • TALEN® Technology
    • In-House Manufacturing
  • Pipeline
    • Product Candidates
  • Investors
    • IR Overview
    • News
      • Press releases
      • Events and Webcasts
    • Presentations
      • Corporate presentations
      • Scientific presentations
      • Scientific publications
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • External Auditors
      • Governance Documents
      • General meetings
    • Financial Information
      • SEC filings
      • Financial statements
      • Voting Rights & Share Capital
      • Stock information
    • Shareholders Services
      • IR Inquiries
      • IR FAQ
  • Careers
    • Our culture
    • Job opportunities
  • Contact us
FR
LinkedinX

Events

All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
September 20, 2023 - September 24, 2023

CICON 2023 (CRI-ENCI-AACR 7th International Cancer Immunotherapy Conference)

Read more
September 6, 2023 - September 8, 2023

Advanced Therapies Europe 2023

Read more
August 29, 2023 - September 2, 2023

8th CART TCR Summit

Read more
August 4, 2023 - August 5, 2023

Cellectis to Report Second Quarter 2023 Financial Results on August 3, 2023

Read more
June 12, 2023 - June 16, 2023

44th Annual Goldman Sachs Global Healthcare Conference

Read more
June 8, 2023 - June 12, 2023

European Hematology Association (EHA) Hybrid Congress

Read more
June 7, 2023 - June 10, 2023

Jefferies Healthcare Conference

Read more
May 31, 2023 - June 3, 2023

2nd Cell Potency Assay Summit

Read more
May 22, 2023 - May 26, 2023

5th Allogeneic Cell Therapies Summit

Read more
May 16, 2023 - May 21, 2023

The American Society of Gene and Cell Therapy Annual Meeting

Read more

Posts pagination

← PREV 1 … 10 11 12 13 14 … 48 NEXT →

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US
cellectis

Clinical-stage biotech · Dual-listed on Nasdaq (CLLS) and Euronext Growth (ALCLS).
Paris · New York · Raleigh.

  • ABOUT
    • Our mission
    • Governance
    • Partners
  • SCIENCE
    • Our Genome Engineering Platform
    • TALEN® Technology
    • In-House Manufacturing
  • PIPELINE
    • Product Candidates
  • INVESTORS
    • Events
    • Corporate presentations
    • Scientific presentations
    • Scientific publications
    • Governance Documents
    • ESG report
    • Shareholders Meetings
    • SEC filings
    • Financial statements
    • Voting Rights & Share Capital
    • Stock information
    • PDMR Notifications
    • IR Inquiries
    • IR FAQ
  • Careers
    • Our culture
    • Job opportunities
© 2026 Cellectis — All rights reserved
  • Legal notice
  • Community Guidelines